Novel survivin-related members of the inhibitor of apoptosis (IAP) family.

Suppr

超能文献

作者信息

Wenzel M, Mahotka C, Krieg A, Bachmann A, Schmitt M, Gabbert H E, Gerharz C D

出版信息

Cell Death Differ. 2000 Jul;7(7):682-3. doi: 10.1038/sj.cdd.4400691.

DOI:10.1038/sj.cdd.4400691

PMID:11023343

Abstract

摘要

相似文献

Novel survivin-related members of the inhibitor of apoptosis (IAP) family.

Cell Death Differ. 2000 Jul;7(7):682-3. doi: 10.1038/sj.cdd.4400691.

Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.

Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):580-3.

Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin.

Mol Cell. 2000 Jul;6(1):173-82.

Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.

Histopathology. 2007 Aug;51(2):204-18. doi: 10.1111/j.1365-2559.2007.02738.x. Epub 2007 Jun 8.

Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.

Cancer. 2002 Nov 1;95(9):1938-45. doi: 10.1002/cncr.10898.

A novel homologue of the TIAP/m-survivin gene.

Biochem Biophys Res Commun. 2001 Mar 23;282(1):207-11. doi: 10.1006/bbrc.2001.4549.

Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.

Oncol Rep. 2005 Nov;14(5):1311-6.

Apoptosis-inhibiting activities of BIR family proteins in Xenopus egg extracts.

FEBS J. 2005 May;272(9):2237-50. doi: 10.1111/j.1742-4658.2005.04648.x.

In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.

Liver Int. 2005 Feb;25(1):77-84. doi: 10.1111/j.1478-3231.2004.0979.x.

Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.

Oncol Rep. 2004 Dec;12(6):1189-94.

引用本文的文献

Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.

Med Sci (Basel). 2016 Oct 17;4(4):16. doi: 10.3390/medsci4040016.

Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.

Curr Pharm Des. 2016;22(28):4360-4373. doi: 10.2174/1381612822666160617112111.

Nanopreparations to overcome multidrug resistance in cancer.

Adv Drug Deliv Rev. 2013 Nov;65(13-14):1748-62. doi: 10.1016/j.addr.2013.08.004. Epub 2013 Aug 23.

Clinico-pathologic relevance of Survivin splice variant expression in cancer.

Cancer Lett. 2013 Oct 10;339(2):167-74. doi: 10.1016/j.canlet.2013.06.007. Epub 2013 Jun 18.

Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.

Anticancer Drugs. 2013 Jan;24(1):66-72. doi: 10.1097/CAD.0b013e3283584f75.

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.

Br J Cancer. 2002 Mar 4;86(5):737-43. doi: 10.1038/sj.bjc.6600153.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验